In addition, KRAS protein interacts with immune cells and tumor-associated fibroblasts in the TME, through paracrine secretion of chemokines, such as the granulocyte–macrophage colony-stimulating factor and IL-6, and proangiogenic factors, such as the vascular endothelial growth factor and chemokines [39,41]. This evidence concerns the gene KRAS and neoplasm.